Bristol-Myers Profit Lower, So Are Shares
454567
Bristol-Myers Squibb Co. BMY.N on  Friday said quarterly profit fell 16 percent on special charges  and lower U.S. sales amid competition from rival brands and  cheaper generics.
278626
The company reports mediocre earnings as investors remain nervous about the drug sector.
151605
Drug company MedImmune Inc. said Thursday that fourth quarter earnings fell by a third as higher sales of a childhood respiratory drug were dampened by swelling research and development expenses.
742004
Boston Scientific reported weaker quarterly earnings on higher expenses from its acquisition of the Guidant Corporation.
64070
The drug maker said its fourth-quarter profit fell 70 percent from a year-ago period that included the sale of its consumer health business, but adjusted profit topped Wall Street expectations.
105442
Eli Lilly and Co.  on Thursday forecast profit gains next year below its expected 2006 growth and offered few big surprises at a meeting to describe its experimental drugs, sending shares lower.
347146
AstraZeneca reported a 12.5 percent drop in profit and Bristol-Myers Squibb posted a loss, albeit a narrower one.
43609
Boston Scientific Corp.  posted lower-than-expected quarterly profit on Friday as sales of its flagship drug-eluting heart stents fell by 32 percent.
269107
Pharmaceutical wholesaler McKesson  Corp  reported on Thursday that its quarterly profit  fell 17 percent as results were hit by charges and lower profit  margins on generic drugs.
629634
Pepsi Bottling Group Inc.  posted slightly higher quarterly profit on Tuesday but failed to allay investor concerns about rising costs, sending its shares down as much as 7.7 percent to their lowest level in nearly three months.
30226
Altria Group Inc.  posted lower quarterly profit on Wednesday, due in part to costs for closing a U.S. cigarette plant as it moves some production to Europe in a move to cut costs and reduce excess capacity.
165129
Stocks dropped yesterday as Colgate-Palmolive and Unilever cut profit forecasts, fueling concern that earnings growth is slowing at a time when borrowing costs are headed higher.
333782
Third-quarter profit fell 1 percent, as stronger sales of almost all of the companyâs key drugs could not offset higher production costs and taxes and a restructuring charge.
608964
Avon Products Inc. AVP.N on Friday  posted a 33 percent increase in third-quarter profit, but  continued concerns over weakness in the United states pushed  the stock 7 percent lower.
567027
Profit taking after Wall Street's nine-session rally pushed stocks slightly lower Monday even as oil prices continued their downward trend.
575186
Merck & Co.  on Thursday said its third-quarter profit fell, hurt by negative effects of the recall last month of its Vioxx arthritis drug.
153503
Swiss drugmaker Novartis AG   missed forecasts with a 42 percent drop in  fourth-quarter net profit, hit by generic competition and a  one-off restructuring charge, sending its shares lower.